Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Chun-Yang Fan

Concepts (278)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
14
2010
336
1.780
Why?
Carcinoma, Squamous Cell
15
2010
385
1.700
Why?
DNA Methylation
13
2009
575
1.180
Why?
DNA Glycosylases
5
2011
22
1.120
Why?
Gene Silencing
7
2009
129
1.100
Why?
Promoter Regions, Genetic
11
2009
520
1.070
Why?
DNA Repair
5
2008
203
0.540
Why?
Mitochondria
3
2011
490
0.530
Why?
Adaptor Proteins, Signal Transducing
5
2009
208
0.510
Why?
Polymerase Chain Reaction
11
2009
531
0.490
Why?
Kidney Neoplasms
2
2008
197
0.490
Why?
Carcinoma, Non-Small-Cell Lung
2
2007
164
0.480
Why?
DNA, Neoplasm
10
2008
171
0.480
Why?
Nuclear Proteins
5
2009
253
0.480
Why?
Neoplasm Proteins
4
2005
360
0.430
Why?
Laryngeal Neoplasms
3
2007
55
0.410
Why?
CpG Islands
3
2008
104
0.390
Why?
Vascular Endothelial Growth Factor A
2
2009
232
0.380
Why?
Lung Neoplasms
2
2007
643
0.360
Why?
Microsatellite Instability
1
2009
20
0.360
Why?
Fatty Liver
1
2011
129
0.360
Why?
Immunohistochemistry
7
2012
1090
0.340
Why?
Receptors, Vascular Endothelial Growth Factor
1
2008
25
0.340
Why?
Mitochondrial Proteins
2
2007
121
0.340
Why?
Port-Wine Stain
1
2008
14
0.330
Why?
O(6)-Methylguanine-DNA Methyltransferase
2
2005
10
0.320
Why?
Oxygen
1
2011
361
0.320
Why?
Genes, p16
3
2005
9
0.310
Why?
N-Glycosyl Hydrolases
1
2007
6
0.300
Why?
Lymph Nodes
2
2007
284
0.300
Why?
DNA-(Apurinic or Apyrimidinic Site) Lyase
1
2007
16
0.300
Why?
Carcinoma, Renal Cell
1
2008
120
0.300
Why?
DNA, Mitochondrial
4
2011
186
0.290
Why?
Mitochondria, Liver
1
2007
86
0.290
Why?
Skin
3
2010
469
0.290
Why?
Aged
15
2011
10060
0.290
Why?
Adenoma
1
2008
142
0.280
Why?
Proteoglycans
2
2003
96
0.280
Why?
Cisplatin
3
2007
351
0.280
Why?
Fibroma
1
2006
41
0.270
Why?
Membrane Glycoproteins
2
2003
270
0.250
Why?
Aged, 80 and over
8
2009
3431
0.250
Why?
Survival Analysis
5
2009
736
0.250
Why?
Liver
1
2011
1226
0.250
Why?
Middle Aged
16
2011
13082
0.250
Why?
Carcinoma, Hepatocellular
1
2007
203
0.250
Why?
Ataxia Telangiectasia
1
2004
5
0.240
Why?
Salivary Ducts
1
2003
5
0.240
Why?
DNA Repair Enzymes
1
2004
50
0.240
Why?
Prognosis
7
2007
2126
0.240
Why?
Salivary Gland Neoplasms
1
2003
24
0.240
Why?
Adenocarcinoma, Clear Cell
1
2003
37
0.230
Why?
Humans
36
2013
54391
0.230
Why?
Receptors, Cytoplasmic and Nuclear
1
2003
85
0.230
Why?
Liver Neoplasms
1
2007
352
0.220
Why?
Obesity
1
2011
1203
0.210
Why?
Nitric Oxide Synthase Type III
2
2013
84
0.210
Why?
Adult
14
2011
14207
0.210
Why?
Female
22
2012
28471
0.200
Why?
Male
21
2012
27347
0.200
Why?
Epigenesis, Genetic
1
2004
399
0.190
Why?
Transcription Factors
1
2003
622
0.180
Why?
Skin Transplantation
2
2010
50
0.180
Why?
Antineoplastic Agents
2
2010
1300
0.170
Why?
Carrier Proteins
4
2005
360
0.160
Why?
Skin Neoplasms
4
2008
532
0.160
Why?
Tumor Suppressor Proteins
2
2011
141
0.160
Why?
Loss of Heterozygosity
2
2008
97
0.160
Why?
Survival Rate
3
2009
954
0.150
Why?
DNA Damage
2
2011
357
0.150
Why?
Neoplasm Invasiveness
4
2007
294
0.140
Why?
Ki-67 Antigen
2
2011
63
0.130
Why?
Graft Survival
3
2011
165
0.130
Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
2005
39
0.120
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
674
0.120
Why?
Immunoenzyme Techniques
4
2013
166
0.120
Why?
Cadherins
2
2005
72
0.120
Why?
Algorithms
2
2008
697
0.120
Why?
Keratosis
2
2003
14
0.120
Why?
Prostatic Neoplasms
2
2008
421
0.120
Why?
Thyroid Neoplasms
2
2007
162
0.110
Why?
Receptors, Cell Surface
1
2013
130
0.110
Why?
Carcinoma in Situ
2
2003
74
0.110
Why?
Arteriovenous Malformations
1
2013
66
0.110
Why?
Lymphangioma, Cystic
1
2011
9
0.110
Why?
Laryngectomy
3
2007
28
0.100
Why?
Base Sequence
2
2004
719
0.100
Why?
Leukoplakia, Oral
1
2011
8
0.100
Why?
Aminolevulinic Acid
1
2011
10
0.100
Why?
Lasers, Dye
1
2011
10
0.100
Why?
Endothelium, Lymphatic
1
2011
13
0.100
Why?
Photosensitizing Agents
1
2011
24
0.100
Why?
Antigens, CD
1
2013
242
0.100
Why?
Lymphatic Abnormalities
1
2011
22
0.100
Why?
Wound Healing
2
2010
228
0.100
Why?
Propranolol
1
2012
78
0.100
Why?
Photochemotherapy
1
2011
37
0.100
Why?
Microtubule-Associated Proteins
1
2011
78
0.100
Why?
Cell Line, Tumor
4
2010
1551
0.100
Why?
Homeodomain Proteins
1
2011
82
0.100
Why?
Drug Resistance, Multiple
1
2010
20
0.100
Why?
Taxoids
1
2010
45
0.100
Why?
Laser Therapy
1
2011
91
0.100
Why?
Hemangioma
1
2012
83
0.100
Why?
Biopsy
3
2011
692
0.100
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2010
60
0.090
Why?
Gene Deletion
1
2011
293
0.090
Why?
Neoplasm Staging
3
2007
805
0.090
Why?
Follow-Up Studies
4
2011
2390
0.090
Why?
Gene Expression Regulation, Neoplastic
4
2010
868
0.090
Why?
Mice, Transgenic
1
2011
658
0.080
Why?
Paraffin Embedding
1
2008
56
0.080
Why?
Disease Models, Animal
2
2011
1647
0.080
Why?
Drug Resistance, Neoplasm
1
2010
309
0.080
Why?
Sulfites
1
2008
2
0.080
Why?
Microsatellite Repeats
1
2008
46
0.080
Why?
Neoplasm Seeding
1
2008
5
0.080
Why?
Chordoma
1
2008
10
0.080
Why?
Recurrent Laryngeal Nerve
1
2007
20
0.080
Why?
Laryngeal Nerves
1
2007
19
0.080
Why?
Blood Glucose
1
2011
489
0.080
Why?
Skull Base Neoplasms
1
2008
23
0.080
Why?
Receptors, Thyrotropin
1
2007
7
0.080
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2005
62
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2004
1060
0.080
Why?
Animals
8
2011
14409
0.080
Why?
Apoptosis Regulatory Proteins
2
2005
96
0.080
Why?
Symporters
1
2007
18
0.080
Why?
Methylation
2
2007
130
0.080
Why?
Image Enhancement
1
2007
56
0.080
Why?
Pattern Recognition, Automated
1
2007
45
0.080
Why?
Mice
4
2011
6428
0.080
Why?
Precancerous Conditions
1
2008
93
0.080
Why?
Prostate
1
2008
123
0.080
Why?
Cell Proliferation
1
2011
1097
0.080
Why?
Transgenes
1
2007
55
0.070
Why?
Carcinoma, Papillary
1
2007
65
0.070
Why?
Risk Factors
3
2008
3937
0.070
Why?
Cell Nucleus
1
2007
203
0.070
Why?
Neoplasm Recurrence, Local
2
2008
645
0.070
Why?
Image Interpretation, Computer-Assisted
1
2007
119
0.070
Why?
Syndecans
2
2003
43
0.070
Why?
Child, Preschool
3
2012
4158
0.070
Why?
Artificial Intelligence
1
2007
85
0.070
Why?
MicroRNAs
1
2010
386
0.070
Why?
Protein Transport
1
2007
195
0.070
Why?
Syndecan-1
2
2003
82
0.070
Why?
Child
5
2012
7368
0.070
Why?
RNA, Messenger
2
2007
1203
0.070
Why?
Genomics
1
2008
313
0.070
Why?
Adenomatous Polyposis Coli Protein
1
2005
4
0.070
Why?
Receptors, Atrial Natriuretic Factor
1
2005
6
0.070
Why?
Atrial Natriuretic Factor
1
2005
24
0.070
Why?
Ear, Inner
1
2005
18
0.070
Why?
Guanine
1
2004
42
0.060
Why?
Cell Physiological Phenomena
1
2004
4
0.060
Why?
Melanoma
1
2008
313
0.060
Why?
Cytochromes c
1
2003
41
0.060
Why?
Cell Cycle Proteins
1
2005
198
0.060
Why?
Salivary Proteins and Peptides
1
2003
9
0.060
Why?
Statistics as Topic
1
2003
102
0.060
Why?
Base Pair Mismatch
1
2003
24
0.060
Why?
Isoenzymes
1
2003
177
0.060
Why?
Tunica Intima
1
2003
52
0.060
Why?
Adenocarcinoma, Follicular
1
2003
8
0.060
Why?
DNA Adducts
1
2004
162
0.060
Why?
Adenocarcinoma, Papillary
1
2003
10
0.060
Why?
Adenoma, Oxyphilic
1
2003
17
0.060
Why?
Cell Count
1
2003
181
0.050
Why?
Keratoacanthoma
1
2002
8
0.050
Why?
Retrospective Studies
4
2007
6459
0.050
Why?
DNA-Binding Proteins
1
2005
462
0.050
Why?
Collagen
1
2003
223
0.050
Why?
Lung
1
2005
508
0.050
Why?
Renal Dialysis
1
2003
193
0.050
Why?
Platelet Aggregation Inhibitors
1
2003
179
0.050
Why?
Combined Modality Therapy
4
2004
693
0.050
Why?
Alcohol Drinking
1
2003
259
0.050
Why?
Molecular Sequence Data
1
2003
980
0.050
Why?
Blood Platelets
1
2003
268
0.050
Why?
Blotting, Western
2
2013
684
0.050
Why?
Cohort Studies
1
2005
1546
0.050
Why?
Prevalence
1
2004
1025
0.050
Why?
Adolescent
2
2012
6900
0.050
Why?
Tomography, X-Ray Computed
1
2006
1222
0.050
Why?
Smoking
1
2003
552
0.040
Why?
Random Allocation
2
2010
312
0.040
Why?
Quality of Life
1
2004
924
0.040
Why?
Electrophoresis, Agar Gel
2
2008
12
0.040
Why?
Sensitivity and Specificity
2
2010
922
0.040
Why?
Hyperplasia
2
2008
107
0.030
Why?
Neck Dissection
2
2008
43
0.030
Why?
Dose-Response Relationship, Drug
2
2011
1476
0.030
Why?
Fluorouracil
2
2004
61
0.030
Why?
Photosensitivity Disorders
2
2003
11
0.030
Why?
Cross-Sectional Studies
2
2012
1696
0.030
Why?
Infant
2
2012
3829
0.030
Why?
Lymph Node Excision
2
2004
140
0.030
Why?
Head
1
2013
78
0.030
Why?
Actins
1
2013
132
0.030
Why?
Neck
1
2013
116
0.030
Why?
Lymphocele
1
2011
7
0.030
Why?
Tissue Survival
1
2011
12
0.030
Why?
Antigens, Nuclear
1
2011
24
0.030
Why?
Transplantation, Heterologous
1
2011
76
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2011
55
0.030
Why?
Administration, Topical
1
2011
71
0.030
Why?
Tissue Culture Techniques
1
2011
46
0.030
Why?
Treatment Outcome
3
2011
5612
0.030
Why?
Mice, Nude
1
2011
284
0.020
Why?
Neoplasms, Squamous Cell
1
2010
9
0.020
Why?
Time Factors
2
2010
3210
0.020
Why?
Granulation Tissue
1
2010
12
0.020
Why?
Pharmacogenetics
1
2010
55
0.020
Why?
Myeloid Cells
1
2010
38
0.020
Why?
Tissue and Organ Harvesting
1
2010
27
0.020
Why?
Rats
2
2009
3419
0.020
Why?
Probability
1
2010
177
0.020
Why?
Endothelial Cells
1
2011
294
0.020
Why?
Graft Rejection
1
2010
161
0.020
Why?
Carcinoma
1
2010
154
0.020
Why?
Pilot Projects
1
2011
807
0.020
Why?
Neovascularization, Physiologic
1
2009
72
0.020
Why?
Thymine
1
2008
11
0.020
Why?
Centromere
1
2008
17
0.020
Why?
Microdissection
1
2008
24
0.020
Why?
Chi-Square Distribution
1
2009
318
0.020
Why?
Cell Line, Transformed
1
2008
88
0.020
Why?
Telomere
1
2008
36
0.020
Why?
Melanocytes
1
2008
39
0.020
Why?
Gene Dosage
1
2008
92
0.020
Why?
Iodine
1
2007
12
0.020
Why?
Genetic Markers
1
2008
117
0.020
Why?
Fluorescent Dyes
1
2008
116
0.020
Why?
Mice, Knockout
1
2010
927
0.020
Why?
Fatal Outcome
1
2008
225
0.020
Why?
Cluster Analysis
1
2007
249
0.020
Why?
Predictive Value of Tests
1
2010
1045
0.020
Why?
Epithelial Cells
1
2008
255
0.020
Why?
Round Window, Ear
1
2005
5
0.020
Why?
Buffers
1
2005
10
0.020
Why?
Injections
1
2005
61
0.020
Why?
Rats, Inbred Lew
1
2005
68
0.020
Why?
Phosphates
1
2005
51
0.020
Why?
Prospective Studies
1
2011
2606
0.020
Why?
Drug Combinations
1
2005
128
0.020
Why?
Sodium Chloride
1
2005
67
0.020
Why?
Protein Isoforms
1
2005
124
0.020
Why?
Rats, Sprague-Dawley
1
2009
1664
0.020
Why?
Mice, Inbred C57BL
1
2010
2001
0.020
Why?
Antibodies
1
2005
178
0.020
Why?
Statistics, Nonparametric
1
2004
232
0.010
Why?
Disease-Free Survival
1
2005
488
0.010
Why?
Platelet Adhesiveness
1
2003
13
0.010
Why?
Reproducibility of Results
1
2007
1301
0.010
Why?
Elastin
1
2003
22
0.010
Why?
Polytetrafluoroethylene
1
2003
36
0.010
Why?
Anastomosis, Surgical
1
2003
72
0.010
Why?
DNA Primers
1
2003
225
0.010
Why?
Radiotherapy
1
2004
137
0.010
Why?
Vascular Patency
1
2003
92
0.010
Why?
Radiotherapy, Adjuvant
1
2003
66
0.010
Why?
Dogs
1
2003
216
0.010
Why?
Up-Regulation
1
2005
509
0.010
Why?
Chemotherapy, Adjuvant
1
2003
119
0.010
Why?
Myocytes, Smooth Muscle
1
2003
92
0.010
Why?
Extracellular Matrix
1
2003
111
0.010
Why?
Graft Occlusion, Vascular
1
2003
86
0.010
Why?
Biopsy, Needle
1
2003
195
0.010
Why?
Lymphatic Metastasis
1
2003
256
0.010
Why?
Young Adult
1
2012
4318
0.010
Why?
Thyroidectomy
1
2003
103
0.010
Why?
Stromal Cells
1
2002
79
0.010
Why?
Models, Biological
1
2003
825
0.010
Why?
Arkansas
1
2004
2100
0.010
Why?
Risk Assessment
1
2003
1362
0.010
Why?
Diagnosis, Differential
1
2002
1141
0.010
Why?
Pregnancy
1
2003
2639
0.010
Why?
Fan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Same Department Expand Description